Extraintestinal manifestations of inflammatory bowel disease

被引:69
|
作者
Williams H. [1 ]
Walker D. [1 ]
Orchard T.R. [1 ]
机构
[1] Imperial College London, St. Mary's Hospital, GI Unit, London W2 1NY, Praed Street
关键词
Ulcerative Colitis; Ankylose Spondylitis; Primary Sclerosing Cholangitis; Mesalazine; Pyoderma Gangrenosum;
D O I
10.1007/s11894-008-0108-6
中图分类号
学科分类号
摘要
The idiopathic inflammatory bowel diseases (IBD), Crohn's disease and ulcerative colitis, may be complicated by extraintestinal manifestations (EIMs) in up to 40% of patients. Reports suggest that almost every organ system may be affected. The EIMs are a significant cause of morbidity and may be particularly distressing for the patient. Recent attempts have been made to define the phenotype of IBD in patients of different ethnicities. These studies have highlighted potential racial variations in the prevalence of specific EIMs, findings that are perhaps not surprising given the influence of genetic factors in their pathogenesis. Certain EIMs are related to the activity of the bowel disease, and their management often involves careful monitoring while the IBD is brought under control. Other EIMs, however, typically run a course independent of the IBD activity, and specific, targeted treatments may be required, even including biologic agents such as infliximab. © Springer Science+Business Media, LLC 2008.
引用
收藏
页码:597 / 605
页数:8
相关论文
共 50 条
  • [31] EXTRAINTESTINAL MANIFESTATIONS OF INFLAMMATORY BOWEL-DISEASE IN CHILDREN
    HYAMS, JS
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 1994, 19 (01): : 7 - 21
  • [32] Extraintestinal Manifestations of Inflammatory Bowel Disease and the Influence of Smoking
    Roberts, Henry
    Rai, Shesh N.
    Pan, Jianmin
    Rao, J. Michael
    Keskey, Robert C.
    Kanaan, Ziad
    Short, Ethan P.
    Mottern, Edward
    Galandiuk, Susan
    DIGESTION, 2014, 90 (02) : 122 - 129
  • [34] Treatment of the extraintestinal manifestations of inflammatory bowel disease.
    Bernstein C.N.
    Current Gastroenterology Reports, 2002, 4 (6) : 513 - 516
  • [35] Extraintestinal manifestations in paediatric patients with inflammatory bowel disease
    Shentova-Eneva, R.
    Baycheva, M.
    Hadjiiski, P.
    Kofinova, D.
    Yaneva, P.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S236 - S237
  • [36] EFFECTS OF VEDOLIZUMAB ON EXTRAINTESTINAL MANIFESTATIONS IN INFLAMMATORY BOWEL DISEASE
    Dimopoulos, Christina
    Hung, Kenneth
    Proctor, Deborah
    Ruggiero, Eilzabeth
    Al-Bawardy, Badr
    GASTROENTEROLOGY, 2020, 158 (03) : S32 - S33
  • [37] ECCO Guidelines on Extraintestinal Manifestations in Inflammatory Bowel Disease
    Gordon, Hannah
    Burisch, Johan
    Ellul, Pierre
    Karmiris, Konstantinos
    Katsanos, Konstantinos
    Allocca, Mariangela
    Bamias, Giorgos
    Barreiro-de Acosta, Manuel
    Braithwaite, Tasanee
    Greuter, Thomas
    Harwood, Catherine
    Juillerat, Pascal
    Lobaton, Triana
    Mueller-Ladner, Ulf
    Noor, Nurulamin
    Pellino, Gianluca
    Savarino, Edoardo
    Schramm, Christoph
    Soriano, Alessandra
    Stein, Juergen Michael
    Uzzan, Mathieu
    van Rheenen, Patrick F.
    Vavricka, Stephan R.
    Vecchi, Maurizio
    Zuily, Stephane
    Kucharzik, Torsten
    JOURNAL OF CROHNS & COLITIS, 2024, 18 (01): : 1 - 37
  • [38] EFFECTS OF VEDOLIZUMAB ON EXTRAINTESTINAL MANIFESTATIONS IN INFLAMMATORY BOWEL DISEASE
    Dimopoulos, Christina
    Hung, Kenneth W.
    Proctor, Deborah D.
    Ruggiero, Elizabeth
    Al-Bawardy, Badr
    GASTROENTEROLOGY, 2020, 158 (06) : S675 - S675
  • [39] A Review of Extraintestinal Manifestations and Complications of Inflammatory Bowel Disease
    Annese, Vito
    SAUDI JOURNAL OF MEDICINE & MEDICAL SCIENCES, 2019, 7 (02): : 66 - 73
  • [40] Ustekinumab and vedolizumab for extraintestinal manifestations in inflammatory bowel disease
    Livne-Margolin, M.
    Ling, D.
    Konyo, S. Attia
    Haj, O.
    Abitbol, C. M.
    Ben-Horin, S.
    Kopylov, U.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I429 - I430